Invesco Ltd. Replimune Group, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 180,958 shares of REPL stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

180,958

Previous 85,598 111.4%

Holding current value

$2.26 Million

Previous $770,000 157.53%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.09 - $11.23 $771,462 - $1.07 Million	95,360 Added 111.4%	180,958 $1.98 Million
Q2 2024 Aug 13, 2024	SELL	$5.01 - $9.46 $5,305 - $10,018	-1,059 Reduced 1.22%	85,598 $770,000
Q1 2024 May 14, 2024	BUY	$6.87 - $9.31 $442,682 - $599,908	64,437 Added 290.0%	86,657 $707,000
Q4 2023 Feb 12, 2024	BUY	$6.75 - $16.18 $189 - $453	28 Added 0.13%	22,220 $187,000
Q3 2023 Nov 13, 2023	BUY	$15.96 - $22.18 $69,042 - $95,950	4,326 Added 24.21%	22,192 $379,000
Q2 2023 Aug 11, 2023	SELL	$15.65 - $24.1 $26,589 - $40,945	-1,699 Reduced 8.68%	17,866 $414,000
Q1 2023 May 12, 2023	SELL	$17.48 - $29.09 $1.3 Million - $2.17 Million	-74,641 Reduced 79.23%	19,565 $345,000
Q4 2022 Feb 13, 2023	BUY	$17.09 - $27.91 $1.02 Million - $1.67 Million	59,782 Added 173.66%	94,206 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $2,418 - $3,278	155 Added 0.45%	34,424 $594,000
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $45,407 - $68,111	3,409 Added 11.05%	34,269 $599,000
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $281,726 - $549,958	18,486 Added 149.39%	30,860 $523,000
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $30,134 - $40,586	-1,185 Reduced 8.74%	12,374 $335,000
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $2.99 Million - $4.08 Million	-103,225 Reduced 88.39%	13,559 $402,000
Q2 2021 Aug 17, 2021	BUY	$28.5 - $39.37 $3.33 Million - $4.6 Million	116,784 New	116,784 $4.49 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $616M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account